Alnylam Pharmaceuticals has released the Phase III results of the clinical trial ILLUMINATE-A evaluating lumasiran for Primary Hyperoxaluria Type 1 Primary Hyperoxaluria Type 1 (PH1) is a rare diso...
Eli Lilly and AbCellera announced the dosing of the patients suffering from COVID-19 with antibody candidate - LY-CoV555. LY-CoV555 is a neutralizing IgG1 monoclonal antibody (mAb) that targets the spikes of the proteins of SARS-CoV-2. So far, COVID-19 has taken the lives of more than 372,000 people g...
Find MoreAlgernon Pharmaceuticals has announced the submission of an Investigational New Drug (IND) application of its drug, NP-120 for COVID-19. The company has submitted the IND with the US FDA for its planned multinational Phase 2b/3 study of its repurposed drug NP-120 (Ifenprodil) for the treatment of patients ...
Find MoreCOVID-19 is here and is not vanishing anytime soon from our lives as suggested by health bodies, scientists, and researchers. It’s almost been six months since the outbreak occurred in China last year, and countries are still figuring out various ways to overcome its transmission. Though the countries around the wo...
Find MoreModerna Therapeutics has announced the positive results of trials of its COVID-19 vaccine, mRNA-1273. The results of interim Phase I clinical trial showed promising outcomes in terms of efficacy and tolerability and potential of mRNA-1273 against COVID-19. The company received the funds for conductin...
Find MoreTelehealth and online medical services have accorded many opportunities for healthcare professionals and patients around the world. A larger section of society is leveraging online medical services for the treatment, diagnosis, and monitoring of diseases. Due to Covid-19, online health services have registered ...
Find MoreThe Worldwide situation due to novel coronavirus since its outbreak in china is getting worse with each passing day. To flatten the curve, countries around the world have adopted various unprecedented measures. The shutdown and social distancing have slowed down the rate of infection to a larger extent but...
Find MoreThe development of telecommunications and web technologies over the past few decades has brought a revolutionary change in almost every industry. Healthcare industry is no exception to this change. Each day a new application of the internet is in use for better healthcare information and healthcare service del...
Find MoreMerck has collaborated with the Seattle-based Institute for Systems Biology (ISB) to further study novel coronavirus SARS-CoV-2. The primary goal of the collaboration will be to investigate the molecular pathway of SARS-CoV-2 and aetiology of COVID-19 with the intent of finding an effective and standard treatm...
Find MoreNovel coronavirus outbreak has created some unprecedented situations in several domains round the World. No vertical is left untouched as the economy tumbles down impacting the human race. Goals of the several industries such as tourism and hospitality that are hit hard, have shifted as they find new ways to create...
Find MoreThe convergence of technologies and the increasing integration of medical devices to computer networ.....
Find MoreOver the last months, the world has faced one of the most unexpected challenges in the form of a nov.....
Find MoreAtopic Dermatitis is a chronic inflammatory disease of the skin, which causes the skin to turn red a.....
Find MoreNeuroendocrine tumors (NET) are a rare kind neoplasm that arises from cells of the endocrine (hormon.....
Find MoreIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive form of interstitial lung disease (ILD.....
Find MoreThere are about 200 different types of cancer, making it one of the most diverse types of indication.....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.